Follow
Nagesh Kolishetti
Title
Cited by
Cited by
Year
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
N Kolishetti, S Dhar, PM Valencia, LQ Lin, R Karnik, SJ Lippard, R Langer, ...
Proceedings of the National Academy of Sciences 107 (42), 17939-17944, 2010
6632010
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
S Dhar, N Kolishetti, SJ Lippard, OC Farokhzad
Proceedings of the National Academy of Sciences 108 (5), 1850-1855, 2011
5882011
Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt (IV) pro-drug
MA Miller, YR Zheng, S Gadde, C Pfirschke, H Zope, C Engblom, ...
Nature communications 6 (1), 8692, 2015
4522015
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
N Graf, DR Bielenberg, N Kolishetti, C Muus, J Banyard, OC Farokhzad, ...
ACS nano 6 (5), 4530-4539, 2012
3482012
Emerging nanotechnology approaches for HIV/AIDS treatment and prevention
T Mamo, EA Moseman, N Kolishetti, C Salvador-Morales, J Shi, ...
Nanomedicine 5 (2), 269-285, 2010
3052010
Targeted nanoparticles in mitochondrial medicine
RK Pathak, N Kolishetti, S Dhar
Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 7 (3 …, 2015
1462015
Nanoparticles for targeted and temporally controlled drug delivery
A Swami, J Shi, S Gadde, AR Votruba, N Kolishetti, OC Farokhzad
Multifunctional nanoparticles for drug delivery applications: imaging …, 2012
1202012
Nanotechnology inspired tools for mitochondrial dysfunction related diseases
R Wen, B Banik, RK Pathak, A Kumar, N Kolishetti, S Dhar
Advanced drug delivery reviews 99, 52-69, 2016
1142016
Metabolic modulation of the tumor microenvironment leads to multiple checkpoint inhibition and immune cell infiltration
D Kolb, N Kolishetti, B Surnar, S Sarkar, S Guin, AS Shah, S Dhar
ACS nano 14 (9), 11055-11066, 2020
922020
Multifunctional nanoparticles for drug delivery applications: imaging, targeting, and delivery
S Svenson, RK Prud'homme
Springer Science & Business Media, 2012
882012
Nanostructures for drug delivery
SJ Lippard, S Dhar, OC Farokhzad, FX Gu, N Kolishetti
US Patent 8,906,417, 2014
822014
Orally administrable therapeutic synthetic nanoparticle for Zika virus
B Surnar, MZ Kamran, AS Shah, U Basu, N Kolishetti, S Deo, ...
ACS nano 13 (10), 11034-11048, 2019
682019
Particles for multiple agent delivery
OC Farokhzad, N Kolishetti, S Dhar, SJ Lippard, RS Langer, PM Valencia
US Patent App. 13/515,668, 2013
642013
Cannabidiol for neurodegenerative disorders: A comprehensive review
S Bhunia, N Kolishetti, AY Arias, A Vashist, M Nair
Frontiers in pharmacology 13, 989717, 2022
632022
Multifunctionalization of polymers by strain-promoted cycloadditions
PA Ledin, N Kolishetti, GJ Boons
Macromolecules 46 (19), 7759-7768, 2013
622013
A prodrug of two approved drugs, cisplatin and chlorambucil, for chemo war against cancer
RK Pathak, R Wen, N Kolishetti, S Dhar
Molecular cancer therapeutics 16 (4), 625-636, 2017
572017
Evaluation of nanoparticle delivered cisplatin in beagles
B Feldhaeusser, SR Platt, S Marrache, N Kolishetti, RK Pathak, ...
Nanoscale 7 (33), 13822-13830, 2015
452015
Nanocarriers for tracking and treating diseases
S Marrache, R Kumar Pathak, K L Darley, J H Choi, D Zaver, N Kolishetti, ...
Current medicinal chemistry 20 (28), 3500-3514, 2013
452013
Inhibition of Amyloid-Beta production, associated neuroinflammation, and Histone Deacetylase 2-mediated epigenetic modifications prevent neuropathology in Alzheimer’s disease …
VSR Atluri, S Tiwari, M Rodriguez, A Kaushik, A Yndart, N Kolishetti, ...
Frontiers in Aging Neuroscience 11, 342, 2020
422020
Development of therapeutic polymeric nanoparticles for the resolution of inflammation
S Gadde, O Even‐Or, N Kamaly, A Hasija, PG Gagnon, KH Adusumilli, ...
Advanced healthcare materials 3 (9), 1448-1456, 2014
422014
The system can't perform the operation now. Try again later.
Articles 1–20